CIK: 1664251 - Address: Aimmune Therapeutics, Inc., 8000 Marina Boulevard, Suite 300, Brisbane, CA 94005-1884
18 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret11210-10-24-220-14
S%wins505010010010080

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

11/21/18 16:05
11/19/18
AIMTAimmune Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsBarrowcliffe Susan E.CAOGM,EuropS.d-1,20230.040-40-819D
11/21/18 16:05
11/19/18
AIMTAimmune Therapeutics, Inc.DEHealthDrugPharmaceutical PreparationsBarrowcliffe Susan E.CAOGM,EuropM.d1213.020409D
1/4/18 16:05
1/2/18
AIMTAimmune Therapeutics, Inc.HealthDrugPharmaceutical PreparationsBarrowcliffe Susan E.CAOGM,EuropS.d-2,78537.140-75-1000D
1/4/18 16:05
1/2/18
AIMTAimmune Therapeutics, Inc.HealthDrugPharmaceutical PreparationsBarrowcliffe Susan E.CAOGM,EuropM.d2273.020750D
9/27/17 16:05
9/25/17
AIMTAimmune Therapeutics, Inc.HealthDrugPharmaceutical PreparationsBarrowcliffe Susan E.CAOGM,EuropS.d-50025.000-20-1000D
9/27/17 16:05
9/25/17
AIMTAimmune Therapeutics, Inc.HealthDrugPharmaceutical PreparationsBarrowcliffe Susan E.CAOGM,EuropM.d603.020200D
9/7/17 16:05
9/5/17
AIMTAimmune Therapeutics, Inc.HealthDrugPharmaceutical PreparationsBarrowcliffe Susan E.CAOGM,EuropS.dm-40522.000-18-1000D
9/7/17 16:05
9/5/17
AIMTAimmune Therapeutics, Inc.HealthDrugPharmaceutical PreparationsBarrowcliffe Susan E.CAOGM,EuropM.dm563.020180D
7/31/17 17:50
7/27/17
AIMTAimmune Therapeutics, Inc.HealthDrugPharmaceutical PreparationsBarrowcliffe Susan E.CAOGM,EuropS.d-1122.000-1-1000D
7/31/17 17:50
7/27/17
AIMTAimmune Therapeutics, Inc.HealthDrugPharmaceutical PreparationsBarrowcliffe Susan E.CAOGM,EuropM.d23.02010D
7/25/17 18:35
7/21/17
AIMTAimmune Therapeutics, Inc.HealthDrugPharmaceutical PreparationsBarrowcliffe Susan E.CAOGM,EuropS.dm-13422.000-6-1000D
7/25/17 18:35
7/21/17
AIMTAimmune Therapeutics, Inc.HealthDrugPharmaceutical PreparationsBarrowcliffe Susan E.CAOGM,EuropM.dm183.02060D
7/6/17 16:05
7/3/17
AIMTAimmune Therapeutics, Inc.HealthDrugPharmaceutical PreparationsBarrowcliffe Susan E.CAOGM,EuropS.d-30420.260-15-1000D
7/6/17 16:05
7/3/17
AIMTAimmune Therapeutics, Inc.HealthDrugPharmaceutical PreparationsBarrowcliffe Susan E.CAOGM,EuropM.d453.020150D
11/15/16 16:06
11/11/16
AIMTAimmune Therapeutics, Inc.HealthDrugPharmaceutical PreparationsBarrowcliffe Susan E.CAOGM,EuropS.d-50025.005-20-1000D519010563596214-2-5-14-23
11/15/16 16:06
11/11/16
AIMTAimmune Therapeutics, Inc.HealthDrugPharmaceutical PreparationsBarrowcliffe Susan E.CAOGM,EuropM.d603.025200D519010563596214-2-5-14-23
11/10/16 16:05
11/8/16
AIMTAimmune Therapeutics, Inc.HealthDrugPharmaceutical PreparationsBarrowcliffe Susan E.CAOGM,EuropM.d453.023150D2373846637443145-6-24-22
11/10/16 16:05
11/8/16
AIMTAimmune Therapeutics, Inc.HealthDrugPharmaceutical PreparationsBarrowcliffe Susan E.CAOGM,EuropS.d-30020.003-15-1000D2373846637443145-6-24-22

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact